Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$517K Buy
2,484
+1,069
+76% +$232K ﹤0.01% 1022
2023
Q2
$289K Sell
1,415
-246
-15% -$51.7K ﹤0.01% 975
2023
Q1
$416K Sell
1,661
-2,042
-55% -$464K 0.01% 773
2022
Q4
$380K Buy
3,703
+2,076
+128% +$464K 0.01% 821
2022
Q3
$325K Buy
1,627
+311
+24% +$62.9K 0.01% 880
2022
Q2
$239K Buy
1,316
+192
+17% +$36.2K 0.01% 882
2022
Q1
$216K Sell
1,124
-105
-9% -$21.3K 0.01% 872
2021
Q4
$291K Buy
1,229
+97
+9% +$22K 0.01% 721
2021
Q3
$234K Buy
1,132
+70
+7% +$15.5K 0.01% 760
2021
Q2
$234K Buy
+1,062
New +$235K 0.01% 721
2021
Q1
– Sell
-25
Closed -$5K – 976
2020
Q4
$5K Buy
+25
New +$4.75K ﹤0.01% 952
2019
Q1
– Sell
-6
Closed -$1K – 919
2018
Q4
$1K Buy
+6
New +$803 ﹤0.01% 509

Other funds holding IEX

Pathstone Family Office's IEX Position: Q3 2023 in Review

Pathstone Family Office increased its IDEX (IEX) stake by 76% in Q3 2023, buying an estimated $232K and bringing the position to 2,484 shares worth $517K. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

Pathstone Family Office first reported a position in IEX in Q4 2018 and has held it in 12 quarters since. 619 funds tracked by Wall St. Rank hold IEX as of Q3 2023.

  • Pathstone Family Office held 2,484 shares of IDEX worth $517K as of Q3 2023.
  • Pathstone Family Office bought 1,069 IDEX shares in Q3 2023, an estimated $232K.
  • IDEX made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1022 holding.
  • Pathstone Family Office first reported a position in IDEX in Q4 2018 and has held it in 12 quarters since.
  • 619 funds tracked by Wall St. Rank held IDEX as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.